Clorox Company (CLX) | Financial Analysis & Statements
The Clorox Company Large-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.0B
Gross Profit
924.0M
46.48%
Operating Income
420.0M
21.13%
Net Income
336.0M
16.90%
Balance Sheet Metrics
Total Assets
5.6B
Total Liabilities
5.6B
Shareholders Equity
35.0M
Debt to Equity
159.37
Cash Flow Metrics
Operating Cash Flow
266.0M
Free Cash Flow
269.0M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Clorox Company Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 7.1B | 7.1B | 7.4B | 7.1B | 7.3B |
| Cost of Goods Sold | 3.9B | 4.0B | 4.5B | 4.6B | 4.1B |
| Gross Profit | 3.2B | 3.0B | 2.9B | 2.5B | 3.2B |
| Gross Margin % | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% |
| Operating Expenses | |||||
| Research & Development | 121.0M | 126.0M | 138.0M | 132.0M | 149.0M |
| Selling, General & Administrative | 1.9B | 2.2B | 1.9B | 1.7B | 1.8B |
| Other Operating Expenses | - | - | - | -14.0M | - |
| Total Operating Expenses | 2.0B | 2.3B | 2.1B | 1.8B | 1.9B |
| Operating Income | 1.2B | 723.0M | 823.0M | 719.0M | 1.2B |
| Operating Margin % | 16.6% | 10.2% | 11.1% | 10.1% | 16.7% |
| Non-Operating Items | |||||
| Interest Income | 9.0M | 23.0M | 16.0M | 5.0M | 5.0M |
| Interest Expense | 88.0M | 90.0M | 90.0M | 106.0M | 99.0M |
| Other Non-Operating Income | -20.0M | -258.0M | -511.0M | -11.0M | -231.0M |
| Pre-tax Income | 1.1B | 398.0M | 238.0M | 607.0M | 900.0M |
| Income Tax | 254.0M | 106.0M | 77.0M | 136.0M | 181.0M |
| Effective Tax Rate % | 23.6% | 26.6% | 32.4% | 22.4% | 20.1% |
| Net Income | 824.0M | 292.0M | 161.0M | 471.0M | 719.0M |
| Net Margin % | 11.6% | 4.1% | 2.2% | 6.6% | 9.8% |
| Key Metrics | |||||
| EBITDA | 1.4B | 968.0M | 1.1B | 947.0M | 1.4B |
| EPS (Basic) | - | $2.26 | $1.21 | $3.75 | $5.66 |
| EPS (Diluted) | - | $2.25 | $1.20 | $3.73 | $5.58 |
| Basic Shares Outstanding | - | 124174000 | 123589000 | 123113000 | 125570000 |
| Diluted Shares Outstanding | - | 124174000 | 123589000 | 123113000 | 125570000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Clorox Company Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 167.0M | 202.0M | 367.0M | 183.0M | 319.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 805.0M | 695.0M | 688.0M | 681.0M | 604.0M |
| Inventory | 523.0M | 637.0M | 696.0M | 755.0M | 752.0M |
| Other Current Assets | 97.0M | 88.0M | 77.0M | 106.0M | 154.0M |
| Total Current Assets | 1.6B | 1.6B | 1.8B | 1.7B | 1.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 333.0M | 360.0M | 346.0M | 342.0M | 332.0M |
| Goodwill | 3.0B | 3.1B | 3.2B | 4.0B | 4.1B |
| Intangible Assets | 566.0M | 681.0M | 712.0M | 884.0M | 918.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 558.0M | 545.0M | 462.0M | 315.0M | 378.0M |
| Total Non-Current Assets | 4.0B | 4.1B | 4.1B | 4.4B | 4.5B |
| Total Assets | 5.6B | 5.8B | 5.9B | 6.2B | 6.3B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 838.0M | 950.0M | 1.0B | 960.0M | 930.0M |
| Short-term Debt | 91.0M | 88.0M | 137.0M | 315.0M | 381.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 1.9B | 1.6B | 1.9B | 1.8B | 2.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.8B | 2.8B | 2.8B | 2.8B | 2.8B |
| Deferred Tax Liabilities | 20.0M | 22.0M | 28.0M | 66.0M | 67.0M |
| Other Non-Current Liabilities | 28.0M | 536.0M | 523.0M | 486.0M | 457.0M |
| Total Non-Current Liabilities | 3.2B | 3.7B | 3.6B | 3.6B | 3.7B |
| Total Liabilities | 5.1B | 5.3B | 5.6B | 5.4B | 5.7B |
| Equity | |||||
| Common Stock | 131.0M | 131.0M | 131.0M | 131.0M | 131.0M |
| Retained Earnings | 432.0M | 250.0M | 583.0M | 1.0B | 1.0B |
| Treasury Stock | 1.4B | 1.2B | 1.2B | 1.3B | 1.4B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 482.0M | 492.0M | 388.0M | 729.0M | 592.0M |
| Key Metrics | |||||
| Total Debt | 2.9B | 2.9B | 2.9B | 3.1B | 3.2B |
| Working Capital | -311.0M | 48.0M | -89.0M | -59.0M | -227.0M |
Balance Sheet Composition
Clorox Company Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 824.0M | 292.0M | 161.0M | 471.0M | 719.0M |
| Depreciation & Amortization | 219.0M | 235.0M | 236.0M | 224.0M | 211.0M |
| Stock-Based Compensation | 81.0M | 74.0M | 73.0M | 52.0M | 50.0M |
| Working Capital Changes | -202.0M | -266.0M | 355.0M | -115.0M | 19.0M |
| Operating Cash Flow | 878.0M | 261.0M | 714.0M | 656.0M | 977.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 128.0M | 17.0M | 0 | 0 | -85.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 126.0M | 37.0M | 5.0M | 22.0M | -121.0M |
| Financing Activities | |||||
| Share Repurchases | -332.0M | 0 | 0 | -25.0M | -905.0M |
| Dividends Paid | -602.0M | -595.0M | -583.0M | -571.0M | -558.0M |
| Debt Issuance | - | 0 | 0 | 1.1B | 0 |
| Debt Repayment | - | 0 | 0 | -1.4B | 0 |
| Financing Cash Flow | -950.0M | -656.0M | -786.0M | -694.0M | -1.5B |
| Free Cash Flow | 761.0M | 483.0M | 930.0M | 535.0M | 945.0M |
| Net Change in Cash | 54.0M | -358.0M | -67.0M | -16.0M | -638.0M |
Cash Flow Trend
Clorox Company Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.98
Forward P/E
14.59
Price to Book
339.41
Price to Sales
1.76
PEG Ratio
-0.95
Profitability Ratios
Profit Margin
11.17%
Operating Margin
14.05%
Return on Equity
987.18%
Return on Assets
11.31%
Financial Health
Current Ratio
0.74
Debt to Equity
9,191.43
Beta
0.64
Per Share Data
EPS (TTM)
$6.11
Book Value per Share
$-1.03
Revenue per Share
$55.08
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CLX | 11.9B | 15.98 | 339.41 | 987.18% | 11.17% | 9,191.43 |
| Procter & Gamble | 340.5B | 21.55 | 6.48 | 31.56% | 19.30% | 68.72 |
| Colgate-Palmolive | 67.9B | 31.83 | 1,249.55 | 497.47% | 10.46% | 2,343.56 |
| Kimberly-Clark | 47.7B | 19.60 | 43.35 | 207.06% | 12.48% | 595.10 |
| Kenvue | 33.6B | 22.78 | 3.08 | 14.39% | 9.72% | 80.58 |
| Estee Lauder | 28.1B | 124.05 | 6.94 | -4.34% | -1.21% | 232.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.






